GRAHAM PETER LIDGARD
CIK 1216274 · Chief Science Officer · last filed 2021-03-15
GRAHAM PETER LIDGARD is a Chief Science Officer who has filed 62 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for EXAS, was dated Mar 15, 2021. Across all open-market trades the lifetime net is −$51.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $101.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$101.9K
2
62
-$50.95M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EXACT SCIENCES CORP (EXAS) Delisted | Chief Science Officer | 43,040 | $104.91 | $4.52M | -$50.95M | 58 | 2021-03-15 |
| NGEN | Sr. VP R&D, CTO | 59,618 | $1.71 | $101.9K | $708 | 4 | 2009-01-21 |
Recent Filings
62 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-15 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | — | -$4.49M | EDGAR |
| 2021-03-10 | EXACT SCIENCES CORP (EXAS) Delisted | Exer (M) | +4,612 | $100.0K | EDGAR |
| 2021-03-08 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −11,735 | -$1.42M | EDGAR |
| 2021-03-03 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +2,501 | -$349.4K | EDGAR |
| 2021-03-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,660 | -$220.3K | EDGAR |
| 2021-02-25 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +5,733 | -$796.3K | EDGAR |
| 2021-02-23 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | +1,841 | -$304.0K | EDGAR |
| 2018-11-07 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −38,311 | -$2.87M | EDGAR |
| 2018-11-02 | EXACT SCIENCES CORP (EXAS) Delisted | Sell (S) | −79,673 | -$5.71M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.